Ausgabe 1/2021
Inhalt (16 Artikel)
Molecular mechanisms underlining the role of metformin as a therapeutic agent in lung cancer
Ali Fatehi Hassanabad, Kelsey T. MacQueen
The Duchenne muscular dystrophy gene and cancer
Leanne Jones, Michael Naidoo, Lee R. Machado, Karen Anthony
Protein arginine methyltransferase 5: a potential cancer therapeutic target
Yuanyang Yuan, Hong Nie
Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN
Guang Shan, Xike Zhou, Juan Gu, Daoping Zhou, Wei Cheng, Huaiguo Wu, Yueping Wang, Tian Tang, Xuedong Wang
Sp1-mediated up-regulation of lnc00152 promotes invasion and metastasis of retinoblastoma cells via the miR-30d/SOX9/ZEB2 pathway
Yali Gao, Xiaoling Luo, Jun Zhang
Epithelial-stromal communication via CXCL1-CXCR2 interaction stimulates growth of ovarian cancer cells through p38 activation
Geun-Young Park, Harsh B. Pathak, Andrew K. Godwin, Youngjoo Kwon
Circular RNA circNFATC3 acts as a miR-9-5p sponge to promote cervical cancer development by upregulating SDC2
Ningye Ma, Xinhui Li, Heng Wei, Huijie Zhang, Shulan Zhang
Y-box binding protein 1 (YB-1) promotes gefitinib resistance in lung adenocarcinoma cells by activating AKT signaling and epithelial–mesenchymal transition through targeting major vault protein (MVP)
Lei Lou, Juan Wang, Fengzhu Lv, Guohui Wang, Yuehong Li, Lingxiao Xing, Haitao Shen, Xianghong Zhang
Synergistic killing effect of paclitaxel and honokiol in non-small cell lung cancer cells through paraptosis induction
Xiao-Qin Li, Jing Ren, Yi Wang, Jin-Yu Su, Yu-Min Zhu, Chen-Guo Chen, Wei-Guo Long, Qian Jiang, Jian Li
Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation
Octavia Cadassou, Muhammad-Zawwad Raza, Christelle Machon, Laura Gudefin, Célia Armanet, Kamel Chettab, Jérôme Guitton, Maria Grazia Tozzi, Charles Dumontet, Emeline Cros-Perrial, Lars Petter Jordheim
Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling
Ioannis Pozios, Nina N. Seel, Nina A. Hering, Lisa Hartmann, Verena Liu, Peter Camaj, Mario H. Müller, Lucas D. Lee, Christiane J. Bruns, Martin E. Kreis, Hendrik Seeliger
RETRACTED ARTICLE: Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis
Bo Sun, Yang Han, Hong Cai, Hua Huang, Yi Xuan
1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas
Yanyu Zhang, Yuan Xie, Liqun He, Jiefu Tang, Qiyuan He, Qingze Cao, Langjun Cui, Wei Guo, Kai Hua, Anna Dimberg, Liang Wang, Lei Zhang
Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures
T. E. Kähkönen, M. Toriseva, N. Petruk, A.-R. Virta, A. Maher, N. Eigéliené, J. Kaivola, P. Boström, I. Koskivuo, M. Nees, J. M. Tuomela, K. K. Ivaska, P. L. Härkönen
LncRNA ZNF503-AS1 acts as a tumor suppressor in bladder cancer by up-regulating Ca2+ concentration via transcription factor GATA6
Haiqing He, Shuiqing Wu, Kai Ai, Ran Xu, Zhaohui Zhong, Yinhuai Wang, Lei Zhang, Xiaokun Zhao, Xuan Zhu
Correction to: LINC00858 knockdown inhibits gastric cancer cell growth and induces apoptosis through reducing WNK2 promoter methylation
Jiang Du, Yuan Liang, Ji Li, Jin-Ming Zhao, Xu-Yong Lin